Connor Clark & Lunn Investment Management Ltd. Invests $2.90 Million in Addus HomeCare Corporation $ADUS

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Addus HomeCare Corporation (NASDAQ:ADUS) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 28,856 shares of the company’s stock, valued at approximately $2,899,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.15% of Addus HomeCare at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in ADUS. Global Retirement Partners LLC lifted its stake in Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after purchasing an additional 186 shares during the last quarter. Larson Financial Group LLC grew its stake in shares of Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after buying an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC bought a new stake in shares of Addus HomeCare during the fourth quarter worth $29,000. NFJ Investment Group LLC acquired a new position in shares of Addus HomeCare during the second quarter worth $29,000. Finally, Arax Advisory Partners increased its holdings in shares of Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after buying an additional 137 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.10% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on ADUS. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Royal Bank Of Canada increased their target price on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Barclays lifted their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Finally, Citizens Jmp restated a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a report on Monday, May 18th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average price target of $130.88.

Addus HomeCare Stock Down 2.1%

Addus HomeCare stock opened at $115.55 on Friday. The firm has a market cap of $2.16 billion, a price-to-earnings ratio of 20.27, a PEG ratio of 1.58 and a beta of 0.87. Addus HomeCare Corporation has a 52-week low of $87.95 and a 52-week high of $124.43. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The firm has a 50 day moving average price of $111.95 and a two-hundred day moving average price of $102.96.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The company had revenue of $377.41 million for the quarter, compared to analyst estimates of $376.24 million. During the same period in the prior year, the firm posted $1.49 EPS. The company’s quarterly revenue was up 8.0% on a year-over-year basis. Equities analysts predict that Addus HomeCare Corporation will post 6.3 EPS for the current year.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.